Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA)

Cat. No.: HY-130142: Ficha de datos Instrucciones de manejo
FAQs
Technical Support

Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Para uso exclusivo en investigación. No vendemos a pacientes.

Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) Estructura química

No. CAS : 1205744-09-7

Tamaño		Stock
MOQ		Minimum order quantity
50 mg		Obtener un presupuesto
100 mg		Obtener un presupuesto
250 mg		Obtener un presupuesto
Other size		Obtener un presupuesto

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA):

Biotinyl-NH-PEG3-C3-amido-C3-COOH

Other Forms of Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA):

Biotinyl-NH-PEG3-C3-amido-C3-COOH In-stock

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas PROTAC Linkers:

Ver todas las isoformas

PEG Linkers Alkyl-Chain Linkers Alkyl/ether Linkers

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs^[1].
In Vitro	PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) Related Antibodies
Peso molecular	689.95
Fòrmula	C₃₃H₆₃N₅O₈S
No. CAS	1205744-09-7
SMILES	O=C(O)CCCC(NCCCOCCOCCOCCCNC(CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O)=O)=O.CC(N(CC)C(C)C)C
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación	Ficha de datos (263 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. [Content Brief]